For more than a decade, this is usually the time period when companies tout the steps they’re taking to lower carbon ...

Biopharma financings totaled $21.38 billion through May 2025, down sharply from $62.57 billion during the same period in 2024, but roughly in line with levels seen in 2023 and 2022. Biopharma ...

We speak with the Co-Chair of The Left Group in the European Parliament, French MEP Manon Aubry. A noted advocate for ...

Vepdegestrant showed a benefit for patients with ER-positive, HER2-negative, ESR1-mutated breast cancer who had previously received endocrine-based therapy.

Wolfspeed bankruptcy watch, North Carolina lands more data centers, Duke University's funding crunch, and an AI companion ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

A Connecticut doctor who is an expert in his field said it is “one of the silent diseases that does not get the respect it ...

Multiple allies caught in the middle of the implosion between President Donald Trump and Elon Musk were delicately attempting ...

Amitesh Rao, CEO of Leo South Asia, defines success as daily reinvention, driven by strategic depth, capability expansion, ...

As the buzz increases in volume and the clock to kick-off counts down, keep an eye on this Spotlight On page for content ...

About 10 minutes into his bilateral meeting with German Chancellor Friedrich Merz on Thursday, President Donald Trump was ...